心臓不整脈モニタリングデバイス市場：デバイス別、エンドユーザー別-2025-2030年の世界予測

心臓不整脈モニタリングデバイス市場は、2023年に87億6,000万米ドルと評価され、2024年には94億4,000万米ドルに達すると予測され、CAGR 8.03％で成長し、2030年には150億6,000万米ドルに達すると予測されています。

心臓不整脈モニタリングデバイスは不整脈の診断と管理に不可欠であり、治療と予防戦略のための洞察を提供します。この分野では、タイムリーな診断と心疾患の効果的な管理に不可欠な、継続的でリアルタイムのデータ収集と分析が行われます。高度なヘルスケアソリューションを必要とする高齢化社会と相まって、心臓に関連する疾病の有病率が世界的に上昇していることから、このような機器の必要性が高まっています。アプリケーションには、病院環境、外来ケアセンター、家庭用シナリオが含まれ、従来の臨床環境以外での患者モニタリングを強化します。主なエンドユーザーは、ヘルスケア専門家、心臓病クリニック、自己監視を目指す技術力のある患者などです。

市場成長の原動力は、ウェアラブルデバイスやワイヤレスデバイスなどの技術的進歩、予防ヘルスケアに対する意識の高まり、デジタルヘルスケアソリューションを奨励する政府の支援策などです。接続性と予測分析のためのAIや機械学習との統合は、診断精度と個別化された患者ケアを強化するため、大きな機会をもたらします。こうした動向を活用するため、企業はユーザーフレンドリーなインターフェースの開発とデータ・プライバシーの安全なシステムの開発に投資することが推奨されます。しかし、課題としては、高い機器コスト、厳しい規制の枠組み、限られた償還シナリオなどがあり、普及の妨げとなっています。

成長の可能性を最大化するためには、患者の快適性とコンプライアンスを高めるために、機器の精度向上、バッテリー寿命の延長、小型化の改善に重点を置いた技術革新が必要です。これらの技術的ハードルに対処することで、市場導入に大きな弾みをつけることができます。さらに、ハイテク企業や研究機関との戦略的提携は、新しい機器の開発と承認プロセスを加速させる可能性があります。全体として、心臓不整脈モニタリング機器市場は依然としてダイナミックであり、規制や経済的課題を背景に新たな機会を捉えるためには継続的な技術革新が必要であり、企業が競争力を維持し、ヘルスケアの進歩に対応できるようにする必要があります。

市場力学：急速に進化する心臓不整脈モニタリングデバイス市場の主要市場インサイトを公開

心臓不整脈モニタリングデバイス市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 世界の心血管障害の有病率の増加
  • 遠隔モニタリングと遠隔医療への傾斜の高まり
  • 消費者によるウェアラブルヘルス技術の採用の増加
• 市場抑制要因
  • 心臓不整脈モニタリングデバイスの開発コストの高さ
• 市場機会
  • 心臓不整脈モニタリングデバイスの進歩
  • 心血管疾患治療に対する政府の償還プログラムおよび政策
• 市場の課題
  • 心臓不整脈モニタリングデバイスの制限と誤作動の問題

ポーターのファイブフォース：心臓不整脈モニタリングデバイス市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、心臓不整脈モニタリングデバイス市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：心臓不整脈モニタリングデバイス市場における外部からの影響の把握

外部マクロ環境要因は、心臓不整脈モニタリングデバイス市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析心臓不整脈モニタリングデバイス市場における競合情勢の把握

心臓不整脈モニタリングデバイス市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス心臓不整脈モニタリングデバイス市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、心臓不整脈モニタリングデバイス市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨心臓不整脈モニタリングデバイス市場における成功への道筋を描く

心臓不整脈モニタリングデバイス市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中で心血管疾患の罹患率が増加
    • 遠隔モニタリングと遠隔医療への関心の高まり
    • 消費者によるウェアラブル健康技術の採用増加
  • 抑制要因
    • 心臓不整脈モニタリングデバイスの開発コストが高い
  • 機会
    • 心臓不整脈モニタリングデバイスの進歩
    • 心血管疾患治療に関する政府の償還プログラムと政策
  • 課題
    • 心臓不整脈モニタリングデバイスの制限と誤動作の問題
• 市場セグメンテーション分析
  • デバイス：心臓の周期における各段階の持続時間とタイミングを検出する心電図モニターの採用が増加
  • エンドユーザー：高精度デバイスを優先する診断センター全体で心臓不整脈モニタリングデバイスの使用が増加しています
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 心臓不整脈モニタリングデバイス市場：デバイス別

• 心電図モニター
• イベントレコーダー
• ホルターモニター
• 埋め込み型心臓モニター
• モバイル心臓テレメトリー

第7章 心臓不整脈モニタリングデバイス市場：エンドユーザー別

• 外来手術センター
• 診断センター
• ホームケア設定
• 病院・クリニック

第8章 南北アメリカの心臓不整脈モニタリングデバイス市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋地域の心臓不整脈モニタリングデバイス市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカの心臓不整脈モニタリングデバイス市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • FDA、次世代AI搭載心電図モニタリング装置を承認
  • FDA、長期不整脈モニタリング用の次世代挿入型デバイスを承認
  • UltraLinQ、アラブヘルスで新しい心臓モニタリング製品を発売
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• ACS Diagnostics, Inc.
• AliveCor, Inc.
• Aspel SA
• BIOTRONIK SE & CO., KG
• BORSAM Biomedical Instruments Co., Ltd.
• Boston Scientific Corporation
• custo med GmbH
• GE HealthCare Technologies, Inc.
• Hillrom Services, Inc. by Baxter International Inc.
• InfoBionic
• iRhythm Technologies, Inc.
• Koninklijke Philips N.V.
• Lepu Medical Technology（Beijing）Co.,Ltd.
• Medtronic PLC
• Nihon Kohden Corporation
• Norav Medical Inc.
• OSI Systems, Inc.
• SCHILLER
• SmartCardia SA
• Stryker Corporation
• UltraLinQ Healthcare Solutions, Inc.
• Viatom Technology Co., Ltd.
• ZOLL Medical Corporation by Asahi Kasei Corporation

LIST OF FIGURES

• FIGURE 1. CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET RESEARCH PROCESS
• FIGURE 2. CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET DYNAMICS
• TABLE 7. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY ELECTROCARDIOGRAM MONITOR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY EVENT RECORDER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY HOLTER MONITOR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY IMPLANTABLE CARDIAC MONITOR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY MOBILE CARDIAC TELEMETRY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 21. ARGENTINA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 22. ARGENTINA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 23. BRAZIL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 24. BRAZIL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 25. CANADA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 26. CANADA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 27. MEXICO CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 28. MEXICO CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 29. UNITED STATES CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 30. UNITED STATES CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 31. UNITED STATES CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 32. ASIA-PACIFIC CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 33. ASIA-PACIFIC CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 34. ASIA-PACIFIC CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 35. AUSTRALIA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 36. AUSTRALIA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 37. CHINA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 38. CHINA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 39. INDIA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 40. INDIA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 41. INDONESIA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 42. INDONESIA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 43. JAPAN CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 44. JAPAN CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 45. MALAYSIA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 46. MALAYSIA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 47. PHILIPPINES CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 48. PHILIPPINES CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 49. SINGAPORE CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 50. SINGAPORE CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 51. SOUTH KOREA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 52. SOUTH KOREA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 53. TAIWAN CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 54. TAIWAN CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 55. THAILAND CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 56. THAILAND CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 57. VIETNAM CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 58. VIETNAM CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 59. EUROPE, MIDDLE EAST & AFRICA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 60. EUROPE, MIDDLE EAST & AFRICA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 61. EUROPE, MIDDLE EAST & AFRICA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 62. DENMARK CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 63. DENMARK CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 64. EGYPT CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 65. EGYPT CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 66. FINLAND CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 67. FINLAND CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 68. FRANCE CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 69. FRANCE CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 70. GERMANY CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 71. GERMANY CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 72. ISRAEL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 73. ISRAEL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 74. ITALY CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 75. ITALY CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 76. NETHERLANDS CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 77. NETHERLANDS CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 78. NIGERIA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 79. NIGERIA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 80. NORWAY CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 81. NORWAY CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 82. POLAND CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 83. POLAND CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 84. QATAR CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 85. QATAR CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 86. RUSSIA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 87. RUSSIA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 88. SAUDI ARABIA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 89. SAUDI ARABIA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 90. SOUTH AFRICA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 91. SOUTH AFRICA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 92. SPAIN CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 93. SPAIN CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 94. SWEDEN CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 95. SWEDEN CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 96. SWITZERLAND CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 97. SWITZERLAND CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 98. TURKEY CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 99. TURKEY CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 100. UNITED ARAB EMIRATES CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 101. UNITED ARAB EMIRATES CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 102. UNITED KINGDOM CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 103. UNITED KINGDOM CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 104. CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 105. CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

The Cardiac Arrhythmia Monitoring Devices Market was valued at USD 8.76 billion in 2023, expected to reach USD 9.44 billion in 2024, and is projected to grow at a CAGR of 8.03%, to USD 15.06 billion by 2030.

Cardiac arrhythmia monitoring devices are critical in diagnosing and managing irregular heartbeats, offering insights for treatment and prevention strategies. The scope involves continuous and real-time data capture and analysis, crucial for timely diagnosis and effective management of cardiac conditions. There is a necessity for such devices given the rising prevalence of heart-related ailments globally, coupled with an aging population that demands advanced healthcare solutions. Applications include hospital settings, ambulatory care centers, and home-use scenarios, enhancing patient monitoring outside traditional clinical environments. Key end-users span healthcare professionals, cardiology clinics, and technologically-enabled patients aiming for self-monitoring.

Market growth is driven by technological advancements, like wearable and wireless devices, increasing awareness of preventive healthcare, and supportive government initiatives that encourage digital healthcare solutions. Connectivity and integration with AI and machine learning for predictive analytics present significant opportunities, as they enhance diagnostic accuracy and personalized patient care. To capitalize on these trends, businesses are advised to invest in the development of user-friendly interfaces and secure systems for data privacy. However, challenging factors include high device costs, stringent regulatory frameworks, and limited reimbursement scenarios that hinder widespread adoption.

For maximum growth potential, innovation must focus on enhancing device accuracy, extending battery life, and improving miniaturization to increase patient comfort and compliance. Addressing these technological hurdles can spur market adoption significantly. Furthermore, strategic collaborations with tech companies and research institutions could accelerate the development and approval processes of new devices. Overall, the cardiac arrhythmia monitoring device market remains dynamic, with continuous innovation necessary for capturing emerging opportunities against a backdrop of regulatory and economic challenges, ensuring companies stay competitive and aligned with healthcare advancements.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cardiac Arrhythmia Monitoring Devices Market

The Cardiac Arrhythmia Monitoring Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing prevalence of cardiovascular disorders worldwide
  • Growing inclination towards remote monitoring and telemedicine
  • Rising adoption of wearable health technologies by consumers
• Market Restraints
  • High cost of development of cardiac arrhythmia monitoring devices
• Market Opportunities
  • Advancements in cardiac arrhythmia monitoring devices
  • Government reimbursement programs and policies for cardiovascular disease treatment
• Market Challenges
  • Limitation and malfunctioning issues with cardiac arrhythmia monitoring devices

Porter's Five Forces: A Strategic Tool for Navigating the Cardiac Arrhythmia Monitoring Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cardiac Arrhythmia Monitoring Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cardiac Arrhythmia Monitoring Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cardiac Arrhythmia Monitoring Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cardiac Arrhythmia Monitoring Devices Market

A detailed market share analysis in the Cardiac Arrhythmia Monitoring Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cardiac Arrhythmia Monitoring Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cardiac Arrhythmia Monitoring Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cardiac Arrhythmia Monitoring Devices Market

A strategic analysis of the Cardiac Arrhythmia Monitoring Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cardiac Arrhythmia Monitoring Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, ACS Diagnostics, Inc., AliveCor, Inc., Aspel SA, BIOTRONIK SE & CO., KG, BORSAM Biomedical Instruments Co., Ltd., Boston Scientific Corporation, custo med GmbH, GE HealthCare Technologies, Inc., Hillrom Services, Inc. by Baxter International Inc., InfoBionic, iRhythm Technologies, Inc., Koninklijke Philips N.V., Lepu Medical Technology(Beijing)Co.,Ltd., Medtronic PLC, Nihon Kohden Corporation, Norav Medical Inc., OSI Systems, Inc., SCHILLER, SmartCardia SA, Stryker Corporation, UltraLinQ Healthcare Solutions, Inc., Viatom Technology Co., Ltd., and ZOLL Medical Corporation by Asahi Kasei Corporation.

Market Segmentation & Coverage

This research report categorizes the Cardiac Arrhythmia Monitoring Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Device, market is studied across Electrocardiogram Monitor, Event Recorder, Holter Monitor, Implantable Cardiac Monitor, and Mobile Cardiac Telemetry.
• Based on End-User, market is studied across Ambulatory Surgical Centers, Diagnostic Centers, Homecare Settings, and Hospitals & Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing prevalence of cardiovascular disorders worldwide
    • 5.1.1.2. Growing inclination towards remote monitoring and telemedicine
    • 5.1.1.3. Rising adoption of wearable health technologies by consumers
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of development of cardiac arrhythmia monitoring devices
  • 5.1.3. Opportunities
    • 5.1.3.1. Advancements in cardiac arrhythmia monitoring devices
    • 5.1.3.2. Government reimbursement programs and policies for cardiovascular disease treatment
  • 5.1.4. Challenges
    • 5.1.4.1. Limitation and malfunctioning issues with cardiac arrhythmia monitoring devices
• 5.2. Market Segmentation Analysis
  • 5.2.1. Device: Growing adoption of electrocardiogram monitors for detecting the duration and timing of each phase in the heart's cycle
  • 5.2.2. End-User: Growing usage of cardiac arrhythmia monitoring devices across diagnostic centers that prioritize high-precision devices
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Cardiac Arrhythmia Monitoring Devices Market, by Device

• 6.1. Introduction
• 6.2. Electrocardiogram Monitor
• 6.3. Event Recorder
• 6.4. Holter Monitor
• 6.5. Implantable Cardiac Monitor
• 6.6. Mobile Cardiac Telemetry

7. Cardiac Arrhythmia Monitoring Devices Market, by End-User

• 7.1. Introduction
• 7.2. Ambulatory Surgical Centers
• 7.3. Diagnostic Centers
• 7.4. Homecare Settings
• 7.5. Hospitals & Clinics

8. Americas Cardiac Arrhythmia Monitoring Devices Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Cardiac Arrhythmia Monitoring Devices Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Cardiac Arrhythmia Monitoring Devices Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
  • 11.3.1. FDA clears next-generation AI-powered ECG monitoring device
  • 11.3.2. FDA clears next-generation insertable device for long-term arrhythmia monitoring
  • 11.3.3. UltraLinQ to launch new cardiac monitoring product at Arab Health
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. ACS Diagnostics, Inc.
• 3. AliveCor, Inc.
• 4. Aspel SA
• 5. BIOTRONIK SE & CO., KG
• 6. BORSAM Biomedical Instruments Co., Ltd.
• 7. Boston Scientific Corporation
• 8. custo med GmbH
• 9. GE HealthCare Technologies, Inc.
• 10. Hillrom Services, Inc. by Baxter International Inc.
• 11. InfoBionic
• 12. iRhythm Technologies, Inc.
• 13. Koninklijke Philips N.V.
• 14. Lepu Medical Technology(Beijing)Co.,Ltd.
• 15. Medtronic PLC
• 16. Nihon Kohden Corporation
• 17. Norav Medical Inc.
• 18. OSI Systems, Inc.
• 19. SCHILLER
• 20. SmartCardia SA
• 21. Stryker Corporation
• 22. UltraLinQ Healthcare Solutions, Inc.
• 23. Viatom Technology Co., Ltd.
• 24. ZOLL Medical Corporation by Asahi Kasei Corporation